WHODrug Standardised Drug Groupings (SDGs)

WHODrug SDGs provide information on how a specific class of drugs may affect the study drug, causing unknown interactions, protocol violations and deviations, and unreported adverse effects.

WHODrug SDGs are specific classifications of drugs of interest, listed according to properties such as their pharmacological effect or metabolic pathway.

Key Features

For more information please contact us at WHODrug@who-umc.org.


Read more

Last modified on: September 17, 2020